Patents Examined by Emily A Cordas
  • Patent number: 9737636
    Abstract: A laminate of a sheet-shaped cell culture is disclosed, which has excellent operability and is suitable for implantation. A method is disclosed for producing a laminate of a fibrin gel and a sheet-shaped cell culture, including a step of dripping a liquid containing fibrinogen onto an upper surface of a sheet-shaped cell culture, a step of spraying a liquid containing thrombin onto the surface, and a step of forming a fibrin gel layer on the surface by a reaction between fibrinogen and thrombin; and a laminate of a fibrin gel and a sheet-shaped cell culture produced by the method are disclosed.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: August 22, 2017
    Assignees: TERUMO KABUSHIKI KAISHA, OSAKA UNIVERSITY
    Inventors: Fumiya Oohashi, Ryouhei Takeuchi, Tadashi Sameshima, Shigeru Miyagawa, Yoshiki Sawa, Atsuhiro Saito
  • Patent number: 9713627
    Abstract: The present invention provides pathogen-inactivated red blood cell compositions suitable for infusion into a subject.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: July 25, 2017
    Assignee: Cerus Corporation
    Inventors: Naheed Mufti, Anna Erickson, Anne North
  • Patent number: 9708584
    Abstract: The present invention relates to a medium composition for transforming stem cells from an aged person into young stem cells, and more particularly to a medium composition for culturing stem cells, which is used to rejuvenate stem cells from an aged person so as to have characteristics similar to those of the stem cells of young people, and to a method for rejuvenating stem cells, which comprises culturing stem cells from an aged person in the medium composition. According to the present invention, even mesenchymal stem cells collected from over 60 years old patients can be transformed into young mesenchymal stem cells having high differentiation ability, high telomerase activity, and high ability to express stem cell markers. Thus, the present invention can significantly increase the efficacy of cell therapy employing mesenchymal stem cells.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: July 18, 2017
    Assignee: R BIO CO., LTD.
    Inventors: Sung Keun Kang, Jeong Chan Ra, Hyeong Geun Park, Hang Young Lee
  • Patent number: 9695457
    Abstract: Methods for the detection or diagnosis of a bacterial infection or colonization utilizing mass spectrometric analysis are provided. The methods involve short-term enrichment of samples followed by mass spectrometric analysis of biomarker profiles. Also provided are methods for preparing short-term enrichment cultures.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: July 4, 2017
    Assignee: OM Research Limited
    Inventor: Pranav Somaiya
  • Patent number: 9683250
    Abstract: Methods of processing paper feedstocks are provided, as well as intermediates and products made using such methods. Certain types of paper feedstocks, in particular highly pigmented papers, and/or highly loaded papers such as paper that has been color printed, e.g., magazines, and high basis weight coated papers, e.g., magazine stock, are utilized to produce useful intermediates and products, such as energy, fuels, foods or materials.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 20, 2017
    Assignee: XYLECO, INC.
    Inventors: Marshall Medoff, Thomas Craig Masterman
  • Patent number: 9663761
    Abstract: A method for maintaining stem cells in the undifferentiated state by mixing the stem cells with at least one extracellular hemoglobin, globin or globin protomer from annelids.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: May 30, 2017
    Assignee: HEMARINA
    Inventor: Franck Zal
  • Patent number: 9663762
    Abstract: Methods for recovering target cells using degradable three dimensional matrices are described.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: May 30, 2017
    Assignee: Ingeneron, Inc.
    Inventors: Michael Coleman, Jody Vykoukal
  • Patent number: 9631178
    Abstract: The present invention relates to isolated human cells that are precursors of endothelial cells other than embryonic stem cells, to isolated murine cells that are precursors of endothelial cells, and to methods using same. In particular, the present invention relates to established cell lines of isolated human cells that are precursors of endothelial cells other than embryonic stem cells and established cell lines of isolated murine cells that are precursors of endothelial cells. The present invention can be used in particular in the medical and/or veterinary fields, in particular in the field of therapeutics and/or in the field of studies of cellular mechanisms.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: April 25, 2017
    Assignees: Centre National de la Recherche Scientifique—CNRS, Ludwick Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy
    Inventors: Claudine Kieda, Catherine Grillon, Nathalie Lamerant-Fayel, Maria Paprocka, Agnieszka Krawczenko, Danuta Goszyk-Dus
  • Patent number: 9624470
    Abstract: This invention relates to hematopoietic precursors derived from human embryonic stem cells. In the culture of differentiated cells from human ES cells, the fully committed hematopoietic precursors are CD34+ and CD43+ but not CD45+. If the cells are cultured until they express CD45, then the cells lose the ability to produce differentiated cells of the lymphoid lineages.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: April 18, 2017
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Igor I. Slukvin, Maksym A. Vodyanyk, James A. Thomson
  • Patent number: 9611457
    Abstract: A method of inducing differentiation of mammalian cells into cardiomyocyte-like cells by contacting the mammalian cell with a triazine compound of formula (I), wherein X is independently —NR4—or —O—, R4 is hydrogen or C1-6-alkyl; R1 is hydroxy, C1-6-alkyl, C1-6-alkoxy, carboxy, C1-6-alkoxycarbonyl, halo, cyano, nitro, formyl, amino, C1-6-alkylamino, or di-C1-6-alkylamino, the C1-6-alkyl or -alkoxy residue being optionally substituted with one or more R5 substituents selected from hydroxy, halo, cyano, and nitro; n is 0 to 5; R2 is hydrogen, aryl, heteroaryl, or C1-6-alkyl, the aryl or heteroaryl residue being optionally substituted with one or more R1 substituents, and where the C1-6-alkyl is optionally further substituted with one or more R5 substituents; and R3 is selected from hydrogen, halo, NR4R7, OR7, SR7, and R7, where the same options apply for R7 as for R2; with the proviso that the compound of formula (I) is not 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: April 4, 2017
    Assignee: TECHNISCHE UNIVERSITAET WIEN
    Inventors: Marko Mihovilovic, Michael Schnuerch, Karlheinz Hilber, Xaver Koenig, Thomas Linder, Agnes Mike
  • Patent number: 9587179
    Abstract: A method to produce biofuels from biomass is provide by contacting the biomass with an aqueous media to form an extracted biomass, separating at least a portion of an aqueous liquor from the extracted biomass thereby providing the aqueous liquor stream comprising soluble carbohydrates; contacting the aqueous liquor stream with a purification substrate effective to remove sulfur compounds and nitrogen compounds thereby producing a treated carbohydrate stream having less than 35% of the sulfur content and less than 35% of the nitrogen content of the untreated aqueous liquor feed, based on the untreated aqueous liquor stream, then contacting the treated carbohydrate stream directly with hydrogen in the presence of a hydrogenolysis catalyst to form a plurality of oxygenated intermediates; and processing at least a portion of the oxygenated intermediates to form a liquid fuel.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: March 7, 2017
    Assignee: SHELL OIL COMPANY
    Inventors: Joseph Broun Powell, Juben Nemchand Chheda
  • Patent number: 9585381
    Abstract: Disclosed is an in vitro or ex vivo method for preserving and/or keeping alive mammalian, preferably human skin biopsies, enabling to transport it and, if applicable, to culture it. Also disclosed is a skin biopsy thus preserved and obtained by such a method and relates to its use as a model especially in a kit for screening or selecting cosmetic or therapeutic compounds.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: March 7, 2017
    Assignee: GENOSKIN
    Inventor: Pascal Descargues
  • Patent number: 9579310
    Abstract: The present invention relates to a method for producing artificial skin, comprising: adding a matrix metalloproteinase inhibitor and a heparanase inhibitor to an artificial skin formation culture medium comprising human epidermal keratinocytes and human dermal fibroblasts, culturing the cells in the artificial skin formation culture medium, and forming artificial skin.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: February 28, 2017
    Assignee: Shiseido Company, Ltd.
    Inventors: Shunsuke Iriyama, Kenichi Umishio, Makoto Tsunenaga, Shinji Inomata, Eijiro Adachi
  • Patent number: 9572833
    Abstract: Compositions and methods for treating red blood cells are disclosed. The methods include contacting a red blood cell sample ex vivo with an amount of nitric oxide or a nitric oxide-releasing compound sufficient to convert at least a portion of the extracellular ferrous hemoglobin present in the red blood cell sample to ferric hemoglobin. Red blood cells administered to a mammal following the ex vivo treatment have reduced adverse effects on the mammal to which they are administered.
    Type: Grant
    Filed: November 6, 2012
    Date of Patent: February 21, 2017
    Assignee: The General Hospital Corporation
    Inventors: Warren M. Zapol, Binglan Yu
  • Patent number: 9572363
    Abstract: The present invention includes a method for enhancing the taste of a food product, which includes the steps of culturing a submerged mycelial liquid tissue culture in a media, collecting the supernatant fluid of the submerged mycelial liquid tissue culture, and adding the collected supernatant fluid to a food product in an amount sufficient to enhance the food product's taste. In one embodiment, the mycelial liquid tissue culture comprises C. sinensis, and the culture step is carried out for between about one and sixty days. The food products include stevia plant parts, steviol glycoside, aspartame, acesulfame-K, sucralose, carbohydrates, monk fruit, cacao, cacao liquor, tea, ginseng, pea protein, sugar alcohol, coffee, cranberry, grapefruit, pomegranate, coconut, wine, beer, liquor and spirits. The present invention also includes products made by the disclosed methods.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: February 21, 2017
    Assignee: MYCOTECHNOLOGY, INC.
    Inventors: James Patrick Langan, Brooks John Kelly, Huntington Davis
  • Patent number: 9574180
    Abstract: A method of obtaining beta-islet cells from pancreases of rabbits and a composition for transplantation (xenografts or xenotransplants) of beta-islet cells isolated and cultured from rabbit pancreases to promote natural insulin production among people with diabetes.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: February 21, 2017
    Assignee: PHILADELPHIA MEDICAL SCIENTIFIC CENTER, L.L.C.
    Inventors: Vladislav Broytman, Nikanor Broytman, Nikolay Skaletskiy
  • Patent number: 9572364
    Abstract: The present invention includes a method for enhancing the taste of a food product, which includes the steps of culturing a submerged mycelial liquid tissue culture in a media, collecting the supernatant fluid of the submerged mycelial liquid tissue culture, and adding the collected supernatant fluid to a food product in an amount sufficient to enhance the food product's taste. In one embodiment, the mycelial liquid tissue culture comprises C. sinensis, and the culture step is carried out for between about one and sixty days. The food products include quinoa, amaranth, whole wheat, stevia plant parts, steviol glycoside, aspartame, acesulfame-K, sucralose, carbohydrates, salt substitutes such as potassium chloride, monk fruit, cacao, cacao liquor, tea, ginseng, pea protein, sugar alcohol, coffee, cranberry, grapefruit, pomegranate, coconut, wine, beer, liquor and spirits. The present invention also includes products made by the disclosed methods.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: February 21, 2017
    Assignee: MYCOTECHNOLOGY, INC.
    Inventors: James Patrick Langan, Brooks John Kelly, Huntington Davis, Bhupendra Kumar Soni
  • Patent number: 9574178
    Abstract: Methods for obtaining purified populations of megakaryocytes and platelets by ex vivo culture of stem cells are provided herein.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: February 21, 2017
    Assignee: New York Blood Center, Inc.
    Inventors: W. Beau Mitchell, Mauro P. Avanzi
  • Patent number: 9556418
    Abstract: Provided herein are methods of culturing organized skeletal muscle tissue from precursor muscle cells by cyclically stretching and relaxing said muscle cells on a support in vitro for a time sufficient to produce said organized skeletal muscle tissue, including reseeding said organized skeletal muscle tissue by contacting additional precursor muscle cells to said organized skeletal muscle tissue on said solid support, and then repeating said step of cyclically stretching and relaxing said muscle cells in said support in vitro for time sufficient to enhance the density (i.e., increased number of nuclei and/or number of multinucleated cells) of said organized skeletal muscle tissue on said support.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: January 31, 2017
    Assignee: Wake Forest University Health Sciences
    Inventors: George J. Christ, Benjamin T. Corona
  • Patent number: 9554578
    Abstract: The present invention provides a method for using a Bacillus strain as a nematicide and related compositions.
    Type: Grant
    Filed: July 24, 2012
    Date of Patent: January 31, 2017
    Assignee: Bayer CropScience LP
    Inventors: Reed Nathan Royalty, Varghese Thomas, Roy Whitson